The similar results to those in the test cohort were observed, the ability of ITGA2B and SELP to distinguish patients with NSCLC from those with non-malignant pulmonary nodules and healthy controls were confirmed. This evidence concerns the gene ITGA2B and non-small cell lung carcinoma.